DUKE UNIVERSITY
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface is a funding opportunity from DUKE UNIVERSITY, up to 764846, closing July 31, 2026.
Jul 31, 2026
(0d left)Overview
Abstract Novel vaccines are needed that have higher efficacy and that provide long-lasting protection against emerging influenza viruses. An attractive approach towards developing a “universal” vaccine is focused on eliciting antibodies that target conserved regions of the hemagglutinin (HA) protein on the surface…